
Muhammed A. Moukhtar Hammad, MBBCh, MSc, discusses real-world trends in baseline erectile dysfunction treatment across AUA sections before minimally invasive BPH procedures.
“The notable finding was that the combination was well tolerated,” says Kelly L. Stratton, MD.
In this video, Kelly L. Stratton, MD, discusses the background, findings, and takeaways of the study, “Novel weekly immunotherapy dosing with avelumab tolerated during Bacillus Calmette-Guerin induction therapy: Initial results of the ABD trial,”
Stratton is an assistant professor of urologic oncology at the University of Oklahoma, Oklahoma City.






